Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lobaplatin vs Cisplatin in Locally Advanced HNSCC
NCT03117257Phase 2Unknown
- Sponsor
- Guizhou Medical University
- Start
- Aug 2016
- Primary completion
- Aug 2019
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of lobaplatin in head and neck squamous cell carcinoma (HNSCC) (2 arms), sponsored by Guizhou Medical University. Primary endpoints: National Cancer Institute CTCAE v4.0 at 1 year and Evaluation of Immediate Efficacy at 1 year. Status: unknown.
02
Drugs
lobaplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT03117257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03117257.